Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hemangiosarcoma × sintilimab × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 2 Rectal Neoplasms 1 Neoplasms, Unknown Primary 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1

Interventions

pembrolizumab 2 Standard of Care 2 Paclitaxel 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 talazoparib 1 sarilumab 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 durvalumab 1 dostarlimab 1 cemiplimab 1 abemaciclib 1 Trastuzumab 1 Specimen Handling 1 STA 9090 1 SGN-LIV1A 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 MK 2206 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡